Welcome to the AD/PD™ 2024 Interactive Program
The conference will officially run on Western European Standard Time (Lisbon, UTC+0)
To convert the conference times to your local time Click Here
Session Time
13:00 - 13:30
Session Type
PRODUCT THEATER
Date
Wed, 06.03.2024
Room
EXHIBITION/PRODUCT THEATER
Session Description
Biofluid-based biomarkers for Alzheimer’s Disease and related disorders - precision, panels and patterns – Supported by Alamar Biosciences.
Session Description:
Dr. Henrik Zetterberg, from the University of Gothenburg, will discuss his efforts to discover and validate blood-based biomarkers for various CNS disorders. During his presentation, he will share recent data from his evaluation of the NULISA immunoassay platform and how it’s high-sensitivity and multiplex content is changing the landscape of blood-based biomarkers for neurodegenerative disease research. Doug Hinerfeld, PhD, from Alamar Biosciences will also discuss the NULISA platform’s multiplex and protein marker detection capabilities in more depth.
NULISA, solving the sensitivity and dynamic range challenge in blood-based protein analysis
Session Type
PRODUCT THEATER
Date
Wed, 06.03.2024
Session Time
13:00 - 13:30
Room
EXHIBITION/PRODUCT THEATER
Lecture Time
13:00 - 13:10
Biofluid-based biomarkers for Alzheimer’s Disease and related disorders - precision, panels and patterns
Session Type
PRODUCT THEATER
Date
Wed, 06.03.2024
Session Time
13:00 - 13:30
Room
EXHIBITION/PRODUCT THEATER
Presenter
Lecture Time
13:10 - 13:30